Operational KPIs
No quarterly operational KPIs found in SEC filings for this company.
Citable operating metrics
ALNY's latest SEC-sourced operating KPI table includes Givlaari Net Product Revenues at 1167175.00 for 2026-03-31.
| Metric | Period | Value | Basis |
|---|---|---|---|
| Givlaari Net Product Revenues | Mar 31, 2026 | 1167175.00 | quarterly |
| Net Product Revenues Amvuttra | Dec 31, 2025 | 826588.00 | quarterly |
| Net Product Revenues Onpattro | Dec 31, 2025 | 31687.00 | quarterly |
| Oxlumo Net Product Revenues | Mar 31, 2026 | 1167175.00 | quarterly |
| Patients Receiving Givlaari | Dec 31, 2025 | 86796.00 | quarterly |
| Patients Receiving Onpattro Amvuttra | Dec 31, 2025 | 826588.00 | quarterly |
| Patients Receiving Oxlumo | Dec 31, 2025 | 49646.00 | quarterly |
| Total Rare Net Product Revenues | Dec 31, 2025 | 136442.00 | quarterly |
Source: SEC EDGAR operating KPI disclosure; period Mar 31, 2026; filed Apr 30, 2026; accession 0001628280-26-028601.
Continue research
Follow same-sector companies and source explainers connected to the kpis view.
A factual guide to operating KPIs — the company-specific metrics in filings, why they are not standardized, and how Aerarium Research surfaces them.
A factual guide to deferred revenue, cash collected before revenue is earned, and why the liability can matter for recurring businesses.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to seasonal revenue patterns and comparable (same-store) sales — why year-over-year comparisons matter and what comp sales strip out.